Loading...
News2017-07-15T01:04:34+00:00

Categories

Archives

PRESS RELEASE: IVI Responds to HHS’ Blueprint Saying Lowering Healthcare Costs Requires Improving Value Assessment

IVI Says Moving Beyond Cost Effectiveness by Evaluating Treatments Based on Unique Patient Characteristics and Preferences is Imperative Los Angeles, CA – July 16, 2018 -- If we are going to truly harness data [...]

July 16th, 2018|IVI News, Press|

Current Problems with Value Assessments and Ideas for Improvement

In an op-ed published by Fierce Healthcare, Director of Scientific Communications, Mark Linthicum discusses current shortfalls of value assessment and what is needed to move to value assessment 2.0. Read the full article here.

July 11th, 2018|Viewpoints|

PRESS RELEASE: Why IVI’s Next Open-Source Modeling Platform Will Focus on Value in Lung Cancer

Los Angeles, CA -- June 20, 2018 -- Oncology is both an area of immense clinical need and a primary driver of healthcare spending. As a result, cancer care is a focus of extensive [...]

June 20th, 2018|IVI News, Press|

An Open-Source Approach Will Drive Healthcare Value Assessment 2.0

Measuring value in healthcare, which frequently takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide relevant and actionable information on value to [...]

June 14th, 2018|IVI News, Press, Viewpoints|

PRESS RELEASE: IVI’s Open-Source Value Project Produces Actionable Data on Value of Rheumatology Treatment Sequencing Designs

Washington, D.C. -- June 14, 2018 -- Measuring value in healthcare, which traditionally takes the perspective of a single payer managing population health and costs, needs to evolve to include diverse perspectives and provide [...]

June 14th, 2018|IVI News, Press|

IVI Leadership Invited to Speak at the 2018 BIO International Convention

The 2018 BIO International Convention will be held in Boston, MA from June 4th through June 7th. IVI’s Jennifer Bright (Acting Executive Director) and Mark Linthicum (Director of Scientific Communications) are among the speakers invited [...]

June 4th, 2018|Event, IVI News|

IVI Demonstrates Commitment to Patient Involvement with Release of “Partnering with Patients” Principles

To demonstrate IVI’s commitment to patient involvement and ensure that the patient perspective is represented in our work, IVI recently developed several documents enumerating the principles and practices that guide this vital partnership. These documents offer detail about the [...]

April 17th, 2018|IVI News|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health [...]

April 16th, 2018|IVI News, Research|

Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play [...]

April 11th, 2018|Viewpoints|

Using Outcomes-Based Pricing for Medical Devices to Improve Cardiovascular Disease Treatment Value

In a post on the IVI-sponsored Health Affairs featured blog series Drugs and Medical Innovation, Daniel Blumenthal, Samuel Nussbaum (IVI Strategic Advisory Panel Chair), Mark Linthicum (IVI Director of Scientific Communications), and Neil Weissman (IVI [...]

March 29th, 2018|Viewpoints|